CareDx Current Ratio 2013-2024 | CDNA

CareDx current ratio from 2013 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
CareDx Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-03-31 $0.30B $0.07B 4.32
2023-12-31 $0.31B $0.08B 4.02
2023-09-30 $0.35B $0.07B 4.75
2023-06-30 $0.36B $0.07B 4.84
2023-03-31 $0.37B $0.07B 5.17
2022-12-31 $0.39B $0.08B 5.11
2022-09-30 $0.39B $0.07B 5.52
2022-06-30 $0.40B $0.08B 5.15
2022-03-31 $0.41B $0.07B 6.15
2021-12-31 $0.43B $0.08B 5.61
2021-09-30 $0.45B $0.07B 6.38
2021-06-30 $0.44B $0.06B 7.84
2021-03-31 $0.44B $0.05B 9.59
2020-12-31 $0.27B $0.07B 3.95
2020-09-30 $0.26B $0.06B 4.14
2020-06-30 $0.25B $0.06B 4.42
2020-03-31 $0.07B $0.03B 2.33
2019-12-31 $0.07B $0.04B 2.07
2019-09-30 $0.07B $0.03B 2.20
2019-06-30 $0.07B $0.03B 2.39
2019-03-31 $0.08B $0.02B 4.74
2018-12-31 $0.08B $0.02B 4.16
2018-09-30 $0.04B $0.02B 2.65
2018-06-30 $0.03B $0.01B 2.16
2018-03-31 $0.03B $0.01B 2.43
2017-12-31 $0.03B $0.04B 0.62
2017-09-30 $0.02B $0.03B 0.55
2017-06-30 $0.02B $0.05B 0.37
2017-03-31 $0.02B $0.05B 0.44
2016-12-31 $0.03B $0.04B 0.65
2016-09-30 $0.04B $0.04B 0.89
2016-06-30 $0.03B $0.04B 0.85
2016-03-31 $0.03B $0.01B 1.94
2015-12-31 $0.03B $0.01B 3.39
2015-09-30 $0.04B $0.01B 3.63
2015-06-30 $0.04B $0.01B 4.85
2015-03-31 $0.04B $0.01B 6.74
2014-12-31 $0.04B $0.01B 3.62
2014-09-30 $0.04B $0.01B 3.78
2014-06-30 $0.01B $0.02B 0.64
2014-03-31 $0.01B $0.01B 0.90
2013-12-31 $0.01B $0.01B 1.08
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.01B $0.01B 1.18
Sector Industry Market Cap Revenue
Medical Medical Services $0.959B $0.280B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $118.753B 14.48
Cencora (COR) United States $45.072B 17.57
ICON (ICLR) Ireland $27.369B 24.59
DiDi Global (DIDIY) China $17.109B 0.00
Avantor (AVTR) United States $15.195B 22.37
CochLear (CHEOY) Australia $14.677B 0.00
Viatris (VTRS) United States $13.931B 4.16
Revvity (RVTY) United States $13.772B 24.16
Natera (NTRA) United States $13.029B 0.00
Medpace Holdings (MEDP) United States $11.839B 35.92
Charles River Laboratories (CRL) United States $11.456B 21.93
Solventum (SOLV) United States $10.033B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $9.918B 0.00
Sonic Healthcare (SKHHY) Australia $8.114B 0.00
HealthEquity (HQY) United States $6.801B 43.67
Bausch + Lomb (BLCO) Canada $5.689B 22.77
Organon (OGN) United States $5.563B 5.28
Doximity (DOCS) United States $5.170B 36.21
PACS (PACS) United States $5.142B 0.00
Life Times (LTH) United States $4.112B 43.08
Sotera Health (SHC) United States $3.787B 18.58
Surgery Partners (SGRY) United States $3.772B 34.51
GoodRx Holdings (GDRX) United States $3.366B 128.14
Agilon Health (AGL) United States $2.780B 0.00
Progyny (PGNY) United States $2.664B 45.87
AMN Healthcare Services Inc (AMN) United States $2.344B 9.29
Premier (PINC) United States $2.118B 9.06
BrightSpring Health Services (BTSG) United States $2.063B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.871B 0.00
Alignment Healthcare (ALHC) United States $1.776B 0.00
Teladoc Health (TDOC) United States $1.565B 0.00
Establishment Labs Holdings (ESTA) $1.315B 0.00
Embecta (EMBC) United States $0.943B 6.41
GeneDx Holdings (WGS) United States $0.884B 0.00
InnovAge Holding (INNV) United States $0.812B 0.00
Auna S.A (AUNA) Luxembourg $0.653B 0.00
Pediatrix Medical (MD) United States $0.646B 6.86
Sharecare (SHCR) United States $0.500B 0.00
Enhabit (EHAB) United States $0.498B 49.65
COMPASS Pathways (CMPS) United Kingdom $0.475B 0.00
Sonida Senior Living (SNDA) United States $0.446B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
ModivCare (MODV) United States $0.331B 6.20
DocGo (DCGO) United States $0.330B 18.06
LifeMD (LFMD) United States $0.283B 0.00
MultiPlan (MPLN) United States $0.281B 0.00
Sera Prognostics (SERA) United States $0.258B 0.00
Beauty Health (SKIN) United States $0.224B 0.00
Ascend Wellness Holdings (AAWH) United States $0.207B 0.00
Biodesix (BDSX) United States $0.187B 0.00
So-Young (SY) China $0.097B 47.00
Pono Capital Two (PTWO) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.043B 5.79
Oncology Institute (TOI) United States $0.042B 0.00
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.037B 0.00
Nutex Health (NUTX) United States $0.037B 0.00
OncoCyte (OCX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.023B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.019B 0.00
TRxADE HEALTH (MEDS) United States $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
XWELL (XWEL) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
Aclarion (ACON) United States $0.003B 0.00